UDR, Inc. (UDR) Announces Management Changes
Get Alerts UDR Hot Sheet
Join SI Premium – FREE
UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust, today announced the following Executive Management promotions and Leadership Transition plans effective January 1, 2025.
First, Mike Lacy has been promoted to Chief Operating Officer (“COO”) after having served as Senior Vice President – Operations since 2019. Mr. Lacy has served in a variety of operational roles since joining UDR in 2006 and has been instrumental in leading the Company’s operating strategy and implementing many of the Company’s innovative initiatives.
Second, Joe Fisher has been appointed to the role of Chief Investment Officer (“CIO”) in addition to his roles as President and Chief Financial Officer ("CFO”). Mr. Fisher, who has served as the Company’s CFO since 2017, will take on the additional responsibilities of overseeing the Company’s investment and development functions.
Furthermore, the Company will initiate an executive search process to recruit a new Chief Financial Officer. Upon the successful hire of a new CFO, Mr. Fisher will relinquish his responsibilities in that capacity and retain the roles of President and Chief Investment Officer.
“On behalf of the Company, our Board, and stakeholders, I would like to thank Joe and Mike for their exemplary leadership and vast contributions to our culture and value creation,” said Tom Toomey, UDR’s Chairman and CEO. “Joe’s transition and elevation to Chief Investment Officer represents a natural expansion of his integral role within the Company. When combined with Mike’s numerous years of operational excellence and expanded role as Chief Operating Officer, we have further aligned the execution of our value creation initiatives across the organization.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RegenxBio completes dosing in RGX-202 confirmatory Duchenne study
- Best Buy launches RGB LED TVs as exclusive national retailer
- Phio Pharmaceuticals begins commercial-scale production of PH-762
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share